In a little over a week the diabetes community will gather in Vienna to discuss all things way cool and whiz bang. Yep, there will be much discussion on the benefits of way cool whiz bang cloud enabled toys. What isn’t likely to be discussed are the mundane things patients use every day, syringes and pen needles. Yet these mundane very boring very low-tech tools make for a very nice and very profitable business and no one does it better than Becton Dickinson (NYSE: BDX).
The company who reported earnings this morning is the unquestioned leader when it . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.